Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinoplasty | 6 | 2023 | 44 | 2.750 |
Why?
|
| Surgical Flaps | 5 | 2023 | 205 | 1.330 |
Why?
|
| Nasal Septum | 3 | 2023 | 17 | 1.060 |
Why?
|
| Nasal Obstruction | 2 | 2023 | 14 | 0.980 |
Why?
|
| Nose Deformities, Acquired | 3 | 2013 | 12 | 0.950 |
Why?
|
| Nasal Septal Perforation | 1 | 2023 | 1 | 0.890 |
Why?
|
| Nasal Mucosa | 2 | 2013 | 65 | 0.820 |
Why?
|
| Soft Tissue Injuries | 1 | 2021 | 11 | 0.740 |
Why?
|
| Facial Injuries | 1 | 2021 | 21 | 0.730 |
Why?
|
| Esthetics, Dental | 2 | 2023 | 16 | 0.440 |
Why?
|
| Orbital Fractures | 2 | 2022 | 38 | 0.390 |
Why?
|
| Temporal Lobe | 2 | 2002 | 116 | 0.370 |
Why?
|
| Fascia | 1 | 2007 | 15 | 0.280 |
Why?
|
| Ear, External | 1 | 2007 | 21 | 0.280 |
Why?
|
| Cartilage | 1 | 2007 | 49 | 0.280 |
Why?
|
| Nose | 2 | 2017 | 92 | 0.230 |
Why?
|
| Maxillary Fractures | 1 | 2022 | 8 | 0.210 |
Why?
|
| Maxillofacial Injuries | 1 | 2022 | 9 | 0.210 |
Why?
|
| Treatment Outcome | 5 | 2023 | 12055 | 0.210 |
Why?
|
| Eye Injuries | 1 | 2022 | 47 | 0.200 |
Why?
|
| Fasciotomy | 1 | 2002 | 26 | 0.200 |
Why?
|
| Ear Diseases | 1 | 2002 | 18 | 0.200 |
Why?
|
| Otologic Surgical Procedures | 1 | 2002 | 23 | 0.200 |
Why?
|
| Enophthalmos | 1 | 2022 | 15 | 0.200 |
Why?
|
| Ear, Middle | 1 | 2001 | 26 | 0.200 |
Why?
|
| Wounds, Gunshot | 1 | 2022 | 137 | 0.190 |
Why?
|
| Cheek | 1 | 2021 | 23 | 0.190 |
Why?
|
| Face | 1 | 2001 | 178 | 0.170 |
Why?
|
| Cicatrix | 1 | 2021 | 125 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 575 | 0.160 |
Why?
|
| Humans | 16 | 2023 | 122633 | 0.140 |
Why?
|
| Palate | 1 | 2017 | 12 | 0.140 |
Why?
|
| Pharynx | 1 | 2017 | 65 | 0.140 |
Why?
|
| Hypnotics and Sedatives | 1 | 2017 | 133 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 2040 | 0.120 |
Why?
|
| Airway Obstruction | 1 | 2017 | 163 | 0.120 |
Why?
|
| Endoscopy | 1 | 2017 | 283 | 0.120 |
Why?
|
| Sleep | 1 | 2017 | 346 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 199 | 0.110 |
Why?
|
| Mandibular Fractures | 1 | 2013 | 7 | 0.110 |
Why?
|
| Bone Plates | 1 | 2013 | 24 | 0.110 |
Why?
|
| Fracture Fixation, Internal | 1 | 2013 | 70 | 0.110 |
Why?
|
| Anthropometry | 2 | 2003 | 189 | 0.100 |
Why?
|
| Reference Values | 2 | 2003 | 694 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2010 | 20 | 0.090 |
Why?
|
| Vertigo | 1 | 2010 | 35 | 0.090 |
Why?
|
| Gout | 1 | 2013 | 142 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2022 | 15916 | 0.090 |
Why?
|
| Adult | 7 | 2022 | 28881 | 0.080 |
Why?
|
| Middle Aged | 7 | 2022 | 25849 | 0.070 |
Why?
|
| Adolescent | 5 | 2022 | 18987 | 0.060 |
Why?
|
| Temporal Arteries | 1 | 2002 | 41 | 0.050 |
Why?
|
| Papilloma | 1 | 2001 | 25 | 0.050 |
Why?
|
| Female | 7 | 2017 | 65117 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2001 | 168 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6012 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 456 | 0.040 |
Why?
|
| Aged | 3 | 2022 | 18982 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2001 | 798 | 0.040 |
Why?
|
| Male | 6 | 2017 | 59714 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2017 | 0.030 |
Why?
|
| Young Adult | 2 | 2022 | 8817 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2001 | 802 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 6341 | 0.020 |
Why?
|
| Child | 2 | 2002 | 24086 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 158 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 586 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1864 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2002 | 13794 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 3256 | 0.010 |
Why?
|
| Desmoplakins | 1 | 2001 | 11 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2001 | 146 | 0.010 |
Why?
|
| Texas | 1 | 2010 | 3541 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2001 | 94 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2013 | 2996 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2001 | 127 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2001 | 137 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 202 | 0.010 |
Why?
|
| Cadherins | 1 | 2001 | 163 | 0.010 |
Why?
|
| Transgenes | 1 | 2001 | 325 | 0.010 |
Why?
|
| beta Catenin | 1 | 2001 | 205 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 240 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 270 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 697 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 648 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 9943 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 2391 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 1872 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 4503 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 17430 | 0.000 |
Why?
|
| Animals | 1 | 2001 | 33618 | 0.000 |
Why?
|